$CLOW
Cloudweb, Inc.

2022 Q1 Form 10-K Financial Statement

#000164033422000465 Filed on March 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 2020 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $19.30K $104.3M $11.63M
YoY Change 13.2% 124.15% -75.0%
% of Gross Profit
Research & Development $0.00
YoY Change -100.0%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $19.30K $34.96K $11.63M
YoY Change 13.2% -99.92% -75.0%
Operating Profit -$9.728K -$195.4K
YoY Change -0.02% 136.03%
Interest Expense $9.728K $195.4K -$15.22K
YoY Change -0.02% 136.03% 62.61%
% of Operating Profit
Other Income/Expense, Net -$9.728K -$195.4K
YoY Change
Pretax Income -$29.03K -$104.5M -$11.65M
YoY Change 8.4% 124.13% -74.97%
Income Tax
% Of Pretax Income
Net Earnings -$29.03K -$104.5M -$11.65M
YoY Change 8.39% 124.13% -74.97%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$1.394K -$327.1M -$36.84M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $57.51K $56.11K
YoY Change 2.4% 1.26%
Accrued Expenses $153.7K $144.6K $107.6K
YoY Change 31.72% 34.41% 41.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $157.6K $157.0K $42.14K
YoY Change 273.9% 272.47% 119.59%
Total Short-Term Liabilities $421.7K $392.6K $205.1K
YoY Change 82.3% 91.41% 29.3%
LONG-TERM LIABILITIES
Long-Term Debt $67.33K $67.33K $179.7K
YoY Change -62.66% -62.54% 1.35%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $67.33K $67.33K $179.7K
YoY Change -62.66% -62.54% 1.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $421.7K $392.6K $205.1K
Total Long-Term Liabilities $67.33K $67.33K $179.7K
Total Liabilities $489.0K $460.0K $384.9K
YoY Change 18.79% 19.51% 14.55%
SHAREHOLDERS EQUITY
Retained Earnings -$128.7M
YoY Change
Common Stock $104.3M $128.4M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$489.0K -$460.0K -$384.9K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2022 Q1 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$29.03K -$104.5M -$11.65M
YoY Change 8.39% 124.13% -74.97%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$17.90K -$34.96K -$6.070K
YoY Change 9.82% 9.42% -12.03%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $17.90K $34.96K 6.070K
YoY Change 9.82% 9.42% -12.03%
NET CHANGE
Cash From Operating Activities -$17.90K -$34.96K -6.070K
Cash From Investing Activities $0.00 0.000
Cash From Financing Activities $17.90K $34.96K 6.070K
Net Change In Cash $0.00 $0.00 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$17.90K -$34.96K -$6.070K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
392620 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
205116 USD
CY2021 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2021Q4 us-gaap Assets Current
AssetsCurrent
0 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
0 USD
CY2021Q4 us-gaap Assets
Assets
0 USD
CY2020Q4 us-gaap Assets
Assets
0 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
56109 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
55409 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
144593 USD
CY2021Q4 us-gaap Notes Payable
NotesPayable
2160 USD
CY2020Q4 us-gaap Notes Payable
NotesPayable
2160 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
1184 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 USD
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
154798 USD
CY2020 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
10030 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 USD
CY2020 us-gaap Professional Fees
ProfessionalFees
24081 USD
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
46500000 USD
CY2021 us-gaap Development Costs
DevelopmentCosts
0 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-46616903 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-384858 USD
CY2021 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
155982 USD
CY2020 us-gaap Development Costs
DevelopmentCosts
10030 USD
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
104250000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-104481070 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-459946 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-104481070 USD
CY2021 us-gaap Salaries And Wages
SalariesAndWages
104250000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3584 USD
CY2020 us-gaap Salaries And Wages
SalariesAndWages
46500000 USD
CY2021 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
104285660 USD
CY2020 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
46534111 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-46616903 USD
CY2021 us-gaap Interest Expense
InterestExpense
195410 USD
CY2020 us-gaap Interest Expense
InterestExpense
82792 USD
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2400 USD
CY2021Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 USD
CY2020Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
112416 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-195410 USD
CY2021Q4 clow Promissory Notes Payable
PromissoryNotesPayable
67326 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-82792 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-104481070 USD
CY2020Q4 clow Promissory Notes Payable
PromissoryNotesPayable
67326 USD
CY2021Q4 us-gaap Liabilities
Liabilities
459946 USD
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
51382 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-46616903 USD
CY2021 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
155982 USD
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-327.13
CY2020Q4 us-gaap Liabilities
Liabilities
384858 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
39982 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
34960 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
128437821 USD
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
319385 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
128437821 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
155982 USD
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-179.97
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
319385 shares
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
259022 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-335967 USD
CY2020 clow Conversion Of Convertible Notes Into Common Stock Amount
ConversionOfConvertibleNotesIntoCommonStockAmount
9000 USD
CY2020 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
48982 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2021Q4 clow Stock Payable
StockPayable
104250000 USD
CY2020Q4 clow Stock Payable
StockPayable
0 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-233207533 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128726463 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-96216 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-96216 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-384858 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2021 us-gaap Professional Fees
ProfessionalFees
35660 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
104250000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
46500000 USD
CY2021 us-gaap Development Costs
DevelopmentCosts
0 USD
CY2020 us-gaap Development Costs
DevelopmentCosts
10030 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
700 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7868 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
37028 USD
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
112416 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
31410 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34960 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31949 USD
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2400 USD
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
51382 USD
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
31949 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34960 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31949 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021 clow Amendment Of Promissory Note To Convertible Note
AmendmentOfPromissoryNoteToConvertibleNote
0 USD
CY2020 clow Amendment Of Promissory Note To Convertible Note
AmendmentOfPromissoryNoteToConvertibleNote
17033 USD
CY2021 clow Conversion Of Convertible Notes For Common Stock
ConversionOfConvertibleNotesForCommonStock
0 USD
CY2020 clow Conversion Of Convertible Notes For Common Stock
ConversionOfConvertibleNotesForCommonStock
9000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
48982 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
154798 USD
CY2020Q4 us-gaap Convertible Debt
ConvertibleDebt
152398 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
1184 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3584 USD
CY2021Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
76921 USD
CY2021 us-gaap Development Costs
DevelopmentCosts
0 USD
CY2020 us-gaap Development Costs
DevelopmentCosts
10030 USD
CY2021 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
57827097 shares
CY2021 us-gaap Operating Expenses
OperatingExpenses
34960 USD
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
69486 USD
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
69486 USD
CY2021 clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 USD
CY2020 clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 USD
CY2021 clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 USD
CY2020 clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 USD
CY2021 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
67672 USD
CY2020 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
45881 USD
CY2021Q4 clow Less Debt Discount
LessDebtDiscount
1184 USD
CY2020Q4 clow Less Debt Discount
LessDebtDiscount
3584 USD
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
154798 USD
CY2020Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
61684 USD
CY2020Q4 us-gaap Convertible Debt
ConvertibleDebt
152398 USD
CY2021Q4 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-154798 USD
CY2020Q4 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-39982 USD
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
300000 shares
CY2020Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
9000 USD
CY2020Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
3000000 shares
CY2020Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.25
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
599656 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
368586 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
125928 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
77403 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
125928 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
77403 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
599656 USD
CY2020 clow Net Operating Loss Carryforward Expiration Year
NetOperatingLossCarryforwardExpirationYear
expire between 2035 and 2041
CY2020Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.50 pure
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25000000 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
104250000 USD

Files In Submission

Name View Source Status
0001640334-22-000465-index-headers.html Edgar Link pending
0001640334-22-000465-index.html Edgar Link pending
0001640334-22-000465.txt Edgar Link pending
0001640334-22-000465-xbrl.zip Edgar Link pending
clow-20211231.xsd Edgar Link pending
clow-20211231_cal.xml Edgar Link unprocessable
clow-20211231_def.xml Edgar Link unprocessable
clow-20211231_lab.xml Edgar Link unprocessable
clow-20211231_pre.xml Edgar Link unprocessable
clow_10k.htm Edgar Link pending
clow_10k_htm.xml Edgar Link completed
clow_ex311.htm Edgar Link pending
clow_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending